Research Articles | Page 2 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights Dec 2013 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Which Patients Should Undergo Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes, and When Should We Do It? Jun 2015 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Where There's Smoke, There's Fire: Inflammation Drives MDS Jul 2020 Trends in immunology myelodysplastic syndromes (MDS)
When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes? Dec 2013 Best Pract Res Clin Haematol myelodysplastic syndromes (MDS)
What causes aplastic anaemia? Apr 2023 Leukemia aplastic anemia
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases Apr 2023 Internal and Emergency Medicine myelodysplastic syndromes (MDS)
Very Severe Aplastic Anemia During Treatment With Doxycycline Oct 2016 Am J Ther. aplastic anemia
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances myelodysplastic syndromes (MDS)
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience Nov 2020 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response Mar 2015 Leuk Res myelodysplastic syndromes (MDS)
Share with addtoany.com.